Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small cell lung cancer
Pharma
AstraZeneca’s Imfinzi tackles another type of lung cancer
The result builds on the immunotherapy’s existing FDA clearance in stage 3 non-small cell lung cancer and extensive-stage small cell lung cancer.
Angus Liu
Apr 5, 2024 10:22am
Jazz's lung cancer drug keeps approval despite failed trial
Oct 26, 2022 2:54pm
Takeda, Daiichi Sankyo, Dizal, Biden and more—Fierce Pharma Asia
Sep 16, 2022 10:15am
Henlius CEO scouts for US PD-1 partner amid Fosun unit's pivot
Aug 30, 2022 1:30am
AstraZeneca adds caregivers to refreshed note card campaign
Apr 5, 2022 7:15am
Jazz charts new path for Zepzelca after SCLC trial flop
Sep 9, 2021 11:00am